IL84294A - In vivo cellular tracking - Google Patents

In vivo cellular tracking

Info

Publication number
IL84294A
IL84294A IL84294A IL8429487A IL84294A IL 84294 A IL84294 A IL 84294A IL 84294 A IL84294 A IL 84294A IL 8429487 A IL8429487 A IL 8429487A IL 84294 A IL84294 A IL 84294A
Authority
IL
Israel
Prior art keywords
cells
vivo
lifetimes
sites
cyanine dyes
Prior art date
Application number
IL84294A
Other languages
English (en)
Other versions
IL84294A0 (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of IL84294A0 publication Critical patent/IL84294A0/xx
Publication of IL84294A publication Critical patent/IL84294A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032Methine dyes, e.g. cyanine dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058Antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0097Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Treating Waste Gases (AREA)
IL84294A 1986-10-31 1987-10-27 In vivo cellular tracking IL84294A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/925,445 US4762701A (en) 1986-10-31 1986-10-31 In vivo cellular tracking

Publications (2)

Publication Number Publication Date
IL84294A0 IL84294A0 (en) 1988-03-31
IL84294A true IL84294A (en) 1992-03-29

Family

ID=25451745

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84294A IL84294A (en) 1986-10-31 1987-10-27 In vivo cellular tracking

Country Status (15)

Country Link
US (1) US4762701A (da)
EP (1) EP0266195B1 (da)
JP (1) JP2872243B2 (da)
KR (1) KR100298682B1 (da)
AT (1) ATE125710T1 (da)
AU (1) AU607165B2 (da)
CA (1) CA1294545C (da)
DE (1) DE3751434T2 (da)
DK (1) DK167957B1 (da)
ES (1) ES2076929T3 (da)
IE (1) IE70749B1 (da)
IL (1) IL84294A (da)
PH (1) PH24539A (da)
PT (1) PT86030B (da)
ZA (1) ZA878116B (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE145337T1 (de) * 1988-05-02 1996-12-15 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
US5135916A (en) * 1989-06-12 1992-08-04 Oklahoma Medical Research Foundation Inhibition of complement mediated inflammatory response
FR2655546B1 (fr) * 1989-12-11 1992-03-13 Assistance Publique Composition pour injection intratumorale, et utilisation pour le marquage prechimiotherapique et preoperatoire, en laserotherapie et en thermotherapie.
JPH06509417A (ja) * 1991-07-16 1994-10-20 トランスメッド バイオテック インコーポレイテッド 多重検体の同時分析の方法と構成
CA2124329C (en) * 1991-11-27 2008-11-18 Gregory A. Kopia Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
US5437274A (en) * 1993-02-25 1995-08-01 Gholam A. Peyman Method of visualizing submicron-size vesicles and particles in blood circulation
WO1994021303A1 (en) * 1993-03-16 1994-09-29 Alliance Pharmaceutical Corp. Fluorocarbon compositions containing a visible or fluorescent label
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
DE19500665A1 (de) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
KR100397020B1 (ko) * 1995-01-30 2004-04-29 다이이치 가가쿠 야쿠힝 가부시키가이샤 진단용마커
DE19539409C2 (de) * 1995-10-11 1999-02-18 Diagnostikforschung Inst Kontrastmittel für die Nahinfrarot-Diagnostik
US6004536A (en) * 1995-11-14 1999-12-21 Molecular Probes, Inc. Lipophilic cyanine dyes with enchanced aqueous solubilty
US5804389A (en) * 1995-12-29 1998-09-08 Phanos Technologies, Inc. Method for detecting abnormal epithelial cell shedding
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US8349602B1 (en) 1996-04-19 2013-01-08 Xenogen Corporation Biodetectors targeted to specific ligands
US5723104A (en) * 1996-05-13 1998-03-03 Fung; Ella Y. Monocyclic functional dyes for contrast enhancement in optical imaging
US5672333A (en) * 1996-05-13 1997-09-30 Mallinckrodt Medical, Inc. Delta1,6 bicyclo 4,4,0! functional dyes for contrast enhancement in optical imaging
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6008010A (en) * 1996-11-01 1999-12-28 University Of Pittsburgh Method and apparatus for holding cells
KR100502440B1 (ko) * 1997-02-04 2005-07-20 파노스 테크놀로지즈 인코포레이티드 비정상적 상피세포의 박리를 측정하는 방법
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
WO1998038490A1 (en) 1997-02-27 1998-09-03 Cellomics, Inc. A system for cell-based screening
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
US5976502A (en) * 1997-10-21 1999-11-02 Gholam A. Peyman Method of visualizing particles and blood cells containing a fluorescent lipophilic dye in the retina and choroid of the eye
US6734338B1 (en) 1997-11-14 2004-05-11 Cedars-Sinai Medical Center Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
AU761758B2 (en) * 1997-11-14 2003-06-12 Cedars-Sinai Medical Center Transfection and transfer of male germ cells for generation of transgenic species
US7294755B1 (en) 1997-11-14 2007-11-13 Cedars-Sinai Medical Center Genetic modification of male germ cells for generation of transgenic species and genetic therapies
US6986993B1 (en) 1999-08-05 2006-01-17 Cellomics, Inc. System for cell-based screening
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
WO2001042786A2 (en) 1999-12-09 2001-06-14 Cellomics, Inc. System for cell based screening : cell spreading
CN1427889B (zh) 2000-01-11 2011-06-29 格林维尔医院系统公司 由抗原提呈细胞可获得的杂交细胞
US20070212338A1 (en) * 2000-01-11 2007-09-13 Greenville Hospital System Hybrid cells
US20090087450A1 (en) * 2000-01-11 2009-04-02 Greenville Hospital System Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
AU2001245424B2 (en) * 2000-03-03 2005-08-18 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US20030223935A1 (en) * 2001-03-05 2003-12-04 Gray Brian D. Fluorescent membrane intercalating probes and methods for their use
US6689391B2 (en) 2001-03-30 2004-02-10 Council Of Scientific & Industrial Research Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
US20020159625A1 (en) * 2001-04-02 2002-10-31 Cytoprint, Inc. Method and apparatus for discovering, identifying and comparing biological activity mechanisms
JP2006519032A (ja) * 2002-12-02 2006-08-24 エダ リサーチ アンド ディベロップメント カンパニー リミティド 光学的な画像化による動脈硬化症の特徴付け
US20060034943A1 (en) * 2003-10-31 2006-02-16 Technology Innovations Llc Process for treating a biological organism
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
WO2006031313A2 (en) * 2004-08-05 2006-03-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for cell activation
TWI306401B (en) * 2004-08-13 2009-02-21 Nat Health Research Institutes Benzothiazolium compounds
JP5306811B2 (ja) 2005-05-11 2013-10-02 ライフ テクノロジーズ コーポレーション 2本鎖dnaへの高い選択性を有する蛍光化学物質及びそれらの使用
AU2005234696B2 (en) 2005-11-18 2012-02-16 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US11052141B1 (en) 2008-10-02 2021-07-06 Kode Biotech Limited Method of modifying the immune response
US20110229511A1 (en) 2008-10-02 2011-09-22 Stephen Michael Henry Method of modifying the immune response
WO2012003334A2 (en) * 2010-06-30 2012-01-05 Case Western Reserve University Molecular probes for imaging of myelin
US20200193156A1 (en) * 2018-12-12 2020-06-18 Tesseract Health, Inc. Biometric identification techniques
CN111334467A (zh) * 2018-12-18 2020-06-26 北京大学 一种光磁双模态指示细胞,其制备方法,其检测方法及其在体内示踪中的应用
US11737665B2 (en) 2019-06-21 2023-08-29 Tesseract Health, Inc. Multi-modal eye imaging with shared optical path

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3673410A (en) * 1969-06-25 1972-06-27 John H Waite Method of examination of cell samples using a radioactively tagged dye
US4343782A (en) * 1978-04-20 1982-08-10 Shapiro Howard M Cytological assay procedure
US4424201A (en) * 1978-11-28 1984-01-03 Rockefeller University Employment of a mereyanine dye for the detection of malignant leukocytic cells
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides

Also Published As

Publication number Publication date
JP2872243B2 (ja) 1999-03-17
AU607165B2 (en) 1991-02-28
CA1294545C (en) 1992-01-21
IL84294A0 (en) 1988-03-31
PT86030B (pt) 1990-08-31
IE70749B1 (en) 1996-12-30
DK167957B1 (da) 1994-01-10
ATE125710T1 (de) 1995-08-15
KR880005458A (ko) 1988-06-29
DE3751434D1 (de) 1995-09-07
PH24539A (en) 1990-08-03
PT86030A (en) 1987-11-01
IE872871L (en) 1988-04-30
DK570487A (da) 1988-05-01
ZA878116B (en) 1988-08-31
DK570487D0 (da) 1987-10-30
EP0266195B1 (en) 1995-08-02
DK167850B1 (da) 1993-12-27
AU8040187A (en) 1988-05-05
KR100298682B1 (ko) 2001-11-22
JPS63126833A (ja) 1988-05-30
ES2076929T3 (es) 1995-11-16
US4762701A (en) 1988-08-09
DE3751434T2 (de) 1996-05-15
EP0266195A1 (en) 1988-05-04

Similar Documents

Publication Publication Date Title
AU607165B2 (en) In vivo cellular tracking
Hegesh et al. A sensitive micromethod for the determination of methemoglobin in blood
Lauf et al. Stimulation of active potassium transport in LK sheep red cells by blood group-L-antiserum
Stroehlein et al. Hemoccult detection of fecal occult blood quantitated by radioassay
Shires et al. Simultaneous measurement of plasma volume, extracellular fluid volume, and red blood cell mass in man utilizing I131, S35O4, and Cr51
JPS5767860A (en) Material for multilayer analysis
BR8800478A (pt) Sistema sensor e metodo para determinar o ph de um meio liquido,sistema sensor e metodo para determinar a concentracao de dioxido de carbono em um meio liquido,e metodo para medir a concentracao de dioxido de carbono em um meio
EP0218010A3 (en) Ligand detection method and substituted carboxyfluorescein tracers therefor
Louderback et al. Clinical Evaluation of a Rapid Screening Test for Sickle Cell Trait (S [unknown]) and Sickle Cell Anemia (SS)
CA1179259A (en) Assay process with non-boiling denaturation
Danon et al. Simple rapid osmotic fragility test proposed as a routine in blood banks
Bellinger et al. Rapid column-chromatographic measurement of orotic acid
Horn et al. Electron spin resonance studies on properties of ceruloplasmin and transferrin in blood from normal human subjects and cancer patients
GB1505262A (en) Composition for use in diagnosing brucella canis infection and a method therefor
Sky-Peck A method for determination of magnesium in serum and urine
SU1436637A1 (ru) Способ определения количества нефти и воды в нефтеводонасыщенных образцах горных пород
NIIZEKI et al. Secondary CO2 diffusion following HCO3-shift across the red blood cell membrane
Husby et al. Oceanographic investigation of the northern Bering Sea and Bering Strait, 8-21 June 1969
Yokoyama et al. Direct immunodiffusion technique for Ig quantitation
Avigad et al. Marking of chloroplast galactolipids with tritium
SU625689A1 (ru) Способ получени пробы крови дл определени объема крови,циркулирующей по сосудам органа
Chodos et al. A study of ferrokinetics and red cell survival in congestive heart failure
Naumann Urobilinogen in cerebrospinal fluid
Ye et al. Rapid detection of adenovirus and rotavirus in stools from infants with diarrhea by polyacrylamide gel electrophoresis.
Ueda et al. A simple radioisotope-labeling method for estimation of globin chain biosynthesis (α/β ratio) in vitro: use of urea cellulose acetate membrane electrophoresis in combination with liquid scintillator counting.

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees